5-minute market readFree every FridayFull PDF included

Scoreboard / AEHR

Aehr Test Systems AEHR

Week of July 10 to July 16, 2026 · Updated July 18, 2026

TechnologyWatch Pullback

Setup Snapshot

The Setup in One Card

How AEHR scored, how it moved against the market, and the catalyst behind the move. A high score means the stock deserves research time, not that it is a buy.

78OF 100

Friday Five Score

Weekly Return vs Benchmarks

AEHR+10.48%
S&P 500-0.13%
Nasdaq-1.24%

Weekly Rank

03 of 5

Sector Trend

Slipping-4.22%

Actionability

Watch Pullback

Catalyst

Guidance Raise

Record bookings and fiscal 2027 guidance of roughly $130 to $150 million, more than double the prior year

Returns are measured from the Thursday, July 9 close to the Thursday, July 16 close. Benchmarks: S&P 500 -0.1% and Nasdaq Composite -1.2% for the week. Benchmark figures are official index closes; sector figures use SPDR sector ETF closes because the official S&P sector index closes for this window were not yet published at press time.

Why It Moved

The Story Behind the Move

AEHR+10.48% this week

Catalyst

After the close on July 14, Aehr reported record bookings and guided next fiscal year to roughly $130 to $150 million in revenue, more than double the prior year, on demand for testing AI and silicon photonics chips, plus a follow on silicon photonics production order.

Why It Mattered

Guidance backed by record bookings and real orders signals a genuine demand inflection, giving a small company years of forward visibility in a corner of the AI supply chain.

Risk Note

A forecast to more than double revenue leans on a handful of large customers, and the stock is small and volatile: it spiked more than 20% intraday before giving much of it back the next day.

Reader Takeaway

Picks and shovels exposure to AI can win even when the big chip names fall, but a small cap riding one theme swings hard in both directions.

← Back to the full scoreboard

This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.